Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Gonzalez-Angulo

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Cancer|August 13, 2011
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancersKanwal P S Raghav, Leonel F Hernandez-Aya, Xiudong Lei, et al.
The Oncologist|September 4, 2007
Trends for inflammatory breast cancer: is survival improving?Ana M Gonzalez-Angulo, Bryan T Hennessy, Kristine Broglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapyJacqueline S Jeruss, Elizabeth A Mittendorf, Susan L Tucker, et al.
Cancer|September 14, 2011
Earlier age of onset of BRCA mutation-related cancers in subsequent generationsJennifer K Litton, Kaylene Ready, Huiqin Chen, et al.
Clinical Breast Cancer|July 19, 2011
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtypeRachel L Theriault, Jennifer K Litton, Elizabeth A Mittendorf, et al.
Breast Cancer Research : BCR|May 25, 2012
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapyAbigail S Caudle, Tse-Kuan Yu, Susan L Tucker, et al.
Clinical Breast Cancer|December 3, 2014
Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomesNapa Parinyanitikul, Xiudong Lei, Mariana Chavez-MacGregor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2011
Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancerHimanshu Nagar, Elizabeth A Mittendorf, Eric A Strom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Cancer|August 13, 2011
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancersKanwal P S Raghav, Leonel F Hernandez-Aya, Xiudong Lei, et al.
The Oncologist|September 4, 2007
Trends for inflammatory breast cancer: is survival improving?Ana M Gonzalez-Angulo, Bryan T Hennessy, Kristine Broglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapyJacqueline S Jeruss, Elizabeth A Mittendorf, Susan L Tucker, et al.
Cancer|September 14, 2011
Earlier age of onset of BRCA mutation-related cancers in subsequent generationsJennifer K Litton, Kaylene Ready, Huiqin Chen, et al.
Clinical Breast Cancer|July 19, 2011
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtypeRachel L Theriault, Jennifer K Litton, Elizabeth A Mittendorf, et al.
Breast Cancer Research : BCR|May 25, 2012
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapyAbigail S Caudle, Tse-Kuan Yu, Susan L Tucker, et al.
Clinical Breast Cancer|December 3, 2014
Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomesNapa Parinyanitikul, Xiudong Lei, Mariana Chavez-MacGregor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2011
Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancerHimanshu Nagar, Elizabeth A Mittendorf, Eric A Strom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
Pageof 15